IRIS
PELLEGRITI, GABRIELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.000
AS - Asia 2.814
EU - Europa 2.787
AF - Africa 399
SA - Sud America 366
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.373
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.804
SG - Singapore 1.226
RU - Federazione Russa 936
CN - Cina 864
IT - Italia 688
BR - Brasile 293
IE - Irlanda 257
CI - Costa d'Avorio 248
VN - Vietnam 222
UA - Ucraina 211
KR - Corea 193
DE - Germania 144
CA - Canada 136
FR - Francia 134
SE - Svezia 101
GB - Regno Unito 88
BD - Bangladesh 79
IN - India 65
NG - Nigeria 56
NL - Olanda 45
FI - Finlandia 40
MX - Messico 35
SN - Senegal 30
AR - Argentina 27
PL - Polonia 25
JP - Giappone 24
ES - Italia 23
ZA - Sudafrica 22
BJ - Benin 17
HK - Hong Kong 17
TR - Turchia 17
CZ - Repubblica Ceca 16
IQ - Iraq 16
CO - Colombia 13
ID - Indonesia 13
UZ - Uzbekistan 11
CH - Svizzera 10
LT - Lituania 10
CL - Cile 9
PK - Pakistan 9
AT - Austria 8
MY - Malesia 8
TT - Trinidad e Tobago 8
AZ - Azerbaigian 6
BE - Belgio 6
LB - Libano 6
PY - Paraguay 6
RO - Romania 6
TN - Tunisia 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
BG - Bulgaria 5
EC - Ecuador 5
KG - Kirghizistan 5
MA - Marocco 5
RS - Serbia 5
BO - Bolivia 4
IR - Iran 4
JM - Giamaica 4
JO - Giordania 4
KE - Kenya 4
PH - Filippine 4
AU - Australia 3
CR - Costa Rica 3
EG - Egitto 3
GR - Grecia 3
KZ - Kazakistan 3
NP - Nepal 3
SI - Slovenia 3
BY - Bielorussia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EE - Estonia 2
ET - Etiopia 2
EU - Europa 2
GA - Gabon 2
GE - Georgia 2
LV - Lettonia 2
MD - Moldavia 2
MT - Malta 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BH - Bahrain 1
BZ - Belize 1
CY - Cipro 1
DK - Danimarca 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
IM - Isola di Man 1
LC - Santa Lucia 1
ML - Mali 1
NO - Norvegia 1
Totale 11.367
Salva come PNG Salva come JPEG
Città #
Singapore 778
Dallas 753
Santa Clara 602
San Jose 461
Moscow 407
Chandler 406
Hefei 271
Dublin 257
Abidjan 248
Ashburn 242
Chicago 227
Jacksonville 194
Seoul 193
Houston 188
Los Angeles 175
Boardman 139
Beijing 133
Lauterbourg 96
Catania 93
Civitanova Marche 89
Grafing 76
Ho Chi Minh City 74
Cambridge 69
Andover 67
Lawrence 67
Nanjing 67
Toronto 66
Buffalo 60
New York 60
Council Bluffs 53
Hanoi 44
Wilmington 40
Rome 37
Montreal 35
São Paulo 35
Orem 32
Dakar 30
Lagos 30
San Mateo 30
Des Moines 29
Brooklyn 26
Nanchang 26
Abuja 24
Munich 24
Tokyo 24
Palermo 22
The Dalles 22
Hebei 21
Pescara 21
Saint Petersburg 21
Amsterdam 20
Columbus 20
Ottawa 20
Bari 19
Chennai 18
Johannesburg 18
Warsaw 18
Cotonou 17
Helsinki 17
Shenyang 17
Stockholm 17
Hong Kong 16
London 16
Kochi 15
Milan 15
Bremen 14
Messina 14
Poplar 13
Rio de Janeiro 13
Seattle 13
Brno 12
Changsha 12
Lappeenranta 12
Mexico City 12
Misterbianco 12
Atlanta 11
Da Nang 11
Frankfurt am Main 11
Marseille 11
Quintano 11
Boston 10
Haiphong 10
Querétaro 10
San Francisco 10
Turku 10
Amantea 9
Dearborn 9
Denver 9
Dong Ket 9
Aci Castello 8
Chieti 8
Iserlohn 8
Jiaxing 8
Naples 8
Norwalk 8
Woodbridge 8
Baghdad 7
Charlotte 7
City of London 7
Manchester 7
Totale 7.799
Salva come PNG Salva come JPEG
Nome #
Time to Separate Persistent from Recurrent Differentiated Thyroid Cancer: Different Conditions with Different Outcomes 293
Role of gender on adverse events in a consecutive series of 28 patients with advanced differentiated thyroid cancer receiving lenvatinib 220
Chemioterapia con fluorouracile (FU) in infusione continua e vinorelbina (VNB) nel carcinoma differenziato della tiroide (CDT) in fase avanzata 192
Absorbed Dose Evaluation in Radioiodine Therapy with Different Approaches 186
Effect of low-dose tungsten on human thyroid stem/precursor cells and their progeny 180
Thyroidectomy as Treatment of Choice for Differentiated Thyroid Cancer 173
Anaplastic thyroid cancer in sicily: The role of environmental characteristics. 167
Outcome of the Diffuse Sclerosing Variant of Papillary Thyroid Cancer: A Meta-Analysis 158
BRAF(V600E) mutation and the biology of papillary thyroid cancer 158
Differentiated thyroid cancer in children: Heterogeneity of predictive risk factors 155
L’ipertiroidismo è un fattore di rischio di trombosi venosa e arteriosa: descrizione di un caso clinico 148
[Differentiated carcinoma of the thyroid in the young. Clinical and histopathologic aspects] 147
A novel RET gene mutation in a patient with apparently sporadic pheochromocytoma 147
Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases 145
Increased thyroid cancer incidence in volcanic areas: A role of increased heavy metals in the environment? 141
Concentration of Metals and Trace Elements in the Normal Human and Rat Thyroid: Comparison with Muscle and Adipose Tissue and Volcanic Versus Control Areas 141
Risk of benign and malignant thyroid disorders in subjects treated for paediatric/adolescent neoplasia: Role of morphological and functional screening 141
Lymph node location is a risk factor for papillary thyroid cancer-related death 139
Differentiated thyroid cancer in children and adolescents 137
Caratteristiche istologiche e cliniche della variante sclerosante diffusa del carcinoma papillifero tiroideo 136
Editorial: Clinical and molecular epidemiology of thyroid cancer of follicular origin 136
Persistenza vs Recidiva di malattia nel Carcinoma Differenziato della Tiroide 135
Association of autoimmune thyroid diseases, chronic atrophic gastritis and gastric carcinoid: experience from a single institution 134
Increased mortality in patients with differentiated thyroid cancer associated with graves' disease 134
Caratteristiche istologiche alla diagnosi e decorso clinico in pazienti tiroidectomizzati per carcinoma papillare variante sclerosante diffusa: studio di metanalisi 133
Orbital metastasis from thyroid cancer: a case report and review of the literature 132
Heavy Metals in the Environment and Thyroid Cancer 132
Caratteristiche cliniche e istologiche di una serie di 23 pazienti affetti da carcinoma tiroideo della cisti del dotto tireoglosso 132
BRAF T1799A Mutation in Thyroid Cancer Predicts Progressive disease 125
Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome 125
Tall cell and diffuse sclerosing variants of papillary thyroid cancer: outcome and predicting value of risk stratification methods 124
Medullary thyroid cancer in MEN2 pediatric/adolescent carriers of RET mutation: genotype/phenotype correlation and outcome in a retrospective series of 23 patients 122
Recurrent parathyromatosis in a patient with concomitant MEN1 and CASR gene alterations: Clinical management of a case report and literature review 120
Early occurrence of a thyroid carcinoma in a patient who developed Graves’ disease after treatment for Hodgkin’s disease 119
Determinants of clinical outcome in patients with moderate/severe Graves' orbitopathy undergoing treatment with parenteral glucocorticoids: a retrospective study 115
Is multifocality a risk factor in low-risk papillary thyroid cancer? 114
Prognostic factors for adrenocortical carcinoma outcomes 113
Immunostaining for Met/HGF receptor may be useful to identify malignancies in thyroid lesions classified suspicious at fine-needle aspiration biopsy 113
Long-term outcome of patients with insular carcinoma of the thyroid 112
Worldwide increasing incidence of thyroid cancer:update on epidemiology and risk factors 111
Soggetti trattati con chemio e/o radioterapia in età pediatrica per neoplasia: patologia tiroidea (morfo-funzione) 111
Pre-Operative Calcitonin and CEA Values May Predict the Extent of Metastases to the Lateral Neck Lymph Nodes in Patients with Medullary Thyroid Cancer 109
Evidenza RMN di metastasi orbitaria da carcinoma papillifero tiroideo avanzato: rara osservazione successiva a remota chemio- e radioterapia per Linfoma non Hodgkin 108
Giant parathyroid adenoma: a rare cause of primary hyperparathyroidism mimicking a carcinoma 108
Outcome of differentiated thyroid cancer in Graves' patients 108
Development of a pediatric differentiated thyroid carcinoma registry within the EuRRECa project: rationale and protocol 107
EP-1773 Radioiodine therapy: a dosimetric study in a patient with DTC after rhTSH stimulation 107
Descriptive epidemiology of human thyroid cancer: Experience from a regional registry and the "volcanic factor" 107
Farmaci innovativi per il trattamento del carcinoma tiroideo avanzato 105
Papillary Thyroid microcarcinomas: a comparative study of the characteristics and risk factors at presentation in two cancer registries 104
Familial non-medullary thyroid cancer represents an independent risk factor for increased cancer aggressiveness: A retrospective analysis of 74 families 103
Response to Letter to the Editor: "Time to Separate Persistent From Recurrent Differentiated Thyroid Cancer: Different Conditions With Different Outcomes" 103
Chemotherapy with continous infusion of fluorouracil (FU) and vinorelbine (VNB) in advanced differentiated thyroid cancer (DTC) 101
Gestione del carcinoma tiroideo in età pediatrica [Management of thyroid carcinoma in the paediatric age] 100
Several site-specific cancers are increased in the volcanic area in Sicily 100
Papillary thyroid cancer incidence in the volcanic area of Sicily 99
Role of gender on adverse events in a consecutive series of 28 patients with advanced differentiated thyroid cancer receiving lenvatinib 98
Antioxidant Defense Capacity Is Reduced in Thyroid Stem/Precursor Cells Compared to Differentiated Thyrocytes 98
Thyroid cancer in thyroglossal dust cyst requires a specific approach due to its unpredictable extension. 98
Thyroid cancer in thyroglossal duct cysts requires a specific approach due to its unpredictable extension. 98
Therapeutic Efficacy of a Very Low/Low Dose of Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer: A Real-World Series from a Single Center 97
Ruolo della 18FDG PET nel follow-up del carcinoma differenziato della tiroide (CDT) in presenza di valori di Tireoglobulina (Tg) indosabili, AAT elevati e TBS post-131-I negativo: esperienza clinica in una paziente 96
Cardiac arrest after intravenous calcium administration for calcitonin stimulation test 96
Prospective study and proposal of an outcome predictive nomogram in a consecutive prospective series of differentiated thyroid cancer based on the new ATA risk categories and TNM 93
Ruolo prognostico dello status linfonodale alla diagnosi sull’evoluzione clinica di 4292 pazienti tiroidectomizzati per carcinoma differenziato della tiroide (CDT) 91
Impact of post-operative radioiodine remnant abalation in differentiated thyroid cancer according to risk categories. 89
Risk-stratified evaluation of over 16000 thyroid microcarcinomas: at presentation more than one third have two or more risk factors for recurrence. 89
Mitotane treatment in patients with adrenocortical cancer causes central hypothyroidism 87
Long-term outcome of medullary thyroid carcinoma in patients with normal postoperative medical imaging 84
The new AJCC/TNM Staging System (VIII ed.) in papillary thyroid cancer: clinical and molecular impact on overall and recurrence free survival 84
The diagnostic use of the rhTSH/thyroglobulin test in differentiated thyroid cancer patients with persistent disease and low thyroglobulin levels 84
Mortality of differentiated thyroid cancer in Graves’s patients. 84
Utilità del dosaggio ultrasensibile della tireoglobulina per il follow-up dei pazienti con carcinoma tiroideo differenziato classificati per livello di rischio di recidiva. 83
Safety and Quality-of-Life Data from an Italian Expanded Access Program of Lenvatinib for Treatment of Thyroid Cancer 83
The tall cell variant of papillary thyroid carcinoma: clinical and pathological features and outcomes. 82
Thyroid Cancer in the Pediatric Age in Sicily: Influence of the Volcanic Environment 82
Usefulness of recombinant human thyrotropin in the radiometabolic treatment of selected patients with thyroid cancer 82
Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients 79
TSH ricombinante umano nei pazienti con carcinoma tiroideo differenziato: utilità del follow-up a breve e a lungo termine 79
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer 78
The BRAF(V600E) mutation influences the short- and medium-term outcomes of classic papillary thyroid cancer, but is not an independent predictor of unfavorable outcome. 78
Valore predittivo del dosaggio della tireoglobulina sierica alla prima valutazione post-tiroidectomia nei pazienti con carcinoma papillifero della tiroide di piccole dimensioni 78
Thyroglobulin measurements after rhTSH stimulation in the follow-up of patients with differentiated thyroid cancer 77
Metastatic malignant struma ovarii with coexistence of Hashimoto’s thyroiditis 76
Prognostic significance of serum Tg in differentiated thyroid cancer (DTC) patients before 131-I ablation and its correlation with neck 131-I uptake. 75
Occurrence of distant metastates as the first sign of disease is a strong prognostic factor of poor outcome in patients with differentiated thyroid cancer 72
Pancreatic Neuroendocrine Tumors: Experience from a Single Institute 71
Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer: A 2015 position statement of the Italian Society of Endocrinology 71
Risk-adapted management of differentiated thyroid cancer assessed by a sensitive measurement of basal serum thyroglobulin. 71
Thyroid Tumor Registry of Sicily: Molecular Epidemiology 69
Usefulness of rhTSH in the management of differentiated thyroid cancer 69
Proposta di modifica della stadiazione TNM dei pazienti con carcinoma tiroideo a bass rischio (stadio I). 69
Update on thyroid cancer treatment 68
Gender Impact on Safety and Efficacy in Lenvatinib treated patients with radioiodine-refractory Differentiated Thyroid Cancer (GISEL study) 67
Predictive factors of persistent disease in a large cohort of pediatric patients with differentiated thyroid carcinoma 66
False positive 131I total body scan due to bilateral polycystic renal disease 64
Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine 64
Response: Re: Papillary thyroid cancer incidence in the volcanic area of sicily 63
The influence of the environment on the development of thyroid tumors: A new appraisal 61
Usefulness of recombinant human TSH (rhTSH) in the radiometabolic treatment of selected thyroid cancer patients 61
Totale 10.969
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.595
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.595
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022484 60 70 3 12 71 2 73 17 46 0 15 115
2022/20231.056 71 67 16 135 98 153 19 193 235 8 32 29
2023/2024671 30 94 20 33 23 166 0 76 9 15 74 131
2024/20252.341 26 372 162 144 475 296 69 69 120 183 201 224
2025/20265.797 349 490 890 346 830 1.123 626 86 394 304 211 148
2026/20278 8 0 0 0 0 0 0 0 0 0 0 0
Totale 11.526